课题基金 / 基金详情

Study of the molecular mechanism of neural tumor formation mediatedby NF1 gene deficiency

Study of the molecular mechanism of neural tumor formation mediatedby NF1 gene deficiency
NF1基因缺陷介导的神经肿瘤形成分子机制研究
批准号:
22390281
负责人:
ARAKI Norie
金额:
$12.23万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

ARAKI Norie的其他基金

相似基金

相关文献

中文摘要
翻译
1型神经纤维瘤病(NF 1)是一种常染色体显性遗传疾病,易发生良性神经纤维瘤和恶性外周神经鞘瘤(MPNSTs)。NF 1相关肿瘤发病机制的分子机制在很大程度上是未知的,NF 1肿瘤的药物治疗策略尚未建立。为了寻找NF 1基因缺陷介导的恶性肿瘤的分子标志物/靶点,我们建立了神经细胞NF 1基因敲低(KD)系统阿萨NF 1疾病模型,并利用整合蛋白质组学技术分析了基因/蛋白表达谱。在4000个非冗余蛋白质中,我们提取了38个分子信号,与对照细胞相比,这些信号在NF 1 KD细胞中异常上调。这些蛋白主要与细胞运动、凋亡和细胞分化有关,其中包括一些新的神经元蛋白网络,如TCTP(Translationally Controlled Tumor Protein)-mTOR信号和Dynein-GR-COX 1信号。我们证实这些信号在NF 1缺陷的神经细胞中通过MAPK/PI 3 K-AKT信号通路的激活而被显著上调。这些信号的敲除或抑制剂处理抑制了NF 1疾病模型/肿瘤细胞的存活和分化。这些结果表明,这些新的NF 1相关信号在功能上与肿瘤的发生和发展有关,并可作为NF 1肿瘤的诊断生物标志物/治疗靶点。
英文摘要
Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder that predisposesindividuals to developing benign neurofibromas and malignant peripheral nerve sheathtumors (MPNSTs). The molecular mechanism of NF1-associated tumor pathogenesis has beenlargely unknown, and the strategy of medical treatments for NF1 tumors has not beenestablished. To identify the molecular marker/target in malignant tumors mediated by NF1gene deficiency, we established the NF1 gene knockdown (KD) system in neural cells asa NF1 disease model, and analyzed the expression profiles of genes/proteins by anintegrated proteomics. Of 4000 non-redundant proteins semi-quantitatively identified,we extracted 38 molecular signals which were abnormally upregulated in NF1 KD cellscompared with control cells. These proteins were mostly related to cell motility,apoptosis, and cell differentiation, and including several novel protein networks inneuronal cells, such as TCTP(Translationally Controlled Tumor Protein)-mTOR signal andDynein-GR-COX1 signal. We confirmed that these signals were significantly up-regulatedin NF1-deficient neural cells via the activation of MAPK/PI3K-AKT signaling in responseto growth factors. The knockdown or inhibitor treatments of these signals suppressed theviability and differentiation of NF1 disease model/tumor cells. These results suggestthat these novel NF1-related signals are functionally implicated in the tumorigenesisand it’s progression, and serves as a diagnostic biomarker/therapeutic target for NF1tumors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
融合プロテオミクスによるNF1特異的タンパク質の同定方法、NF1特異的タンパク質発現抑制方法、およびNF1特異的タンパク質の腫瘍マーカーとしての使用方法
通过融合蛋白质组学鉴定NF1特异性蛋白的方法、抑制NF1特异性蛋白表达的方法以及使用NF1特异性蛋白作为肿瘤标志物的方法
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: []
通讯作者:
Integrated proteomics of brain tumor cellsignals related to chemotherapy sensitivity
与化疗敏感性相关的脑肿瘤细胞信号的综合蛋白质组学
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Souhei Mizuguti , Takashi Morikawa , Nobuyuki Tsubota , Uichi Midorikawa , Akiko Niibori, Daiki Kobayashi, HideoNakamura, Junichi Kuratsu, Norie Araki]
通讯作者: Norie Araki
A proteomic integrated approach for targetingand elucidating the functions of novelproteins involved in neuronal differentiationand disorders
一种蛋白质组学整合方法,用于靶向和阐明参与神经元分化和疾病的新型蛋白质的功能
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Daiki Kobayashi , JiroKumagai , Takashi Morikawa , MioHirayama , Anthony Wilson , MasayoWilson, Norie Araki]
通讯作者: Norie Araki
Analysis of cellular signals activated in the tumor tissue related to chemotherapy snsitivity by Integrated Proteomics
综合蛋白质组学分析肿瘤组织中与化疗敏感性相关的激活细胞信号
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Araki N, Mizuguchi S, Morikawa T, Kobayashi D, Tsubota M, Midorikawa U, Niibori A, Wilson A, Nakamura H, Kuratsu J]
通讯作者: Kuratsu J
共 79 条
    Analysis of molecular network on maintenance and differentiation of glioma stem cells
    • 批准号:
      25640068
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      ARAKI Norie
    • 依托单位:
    System development for microquantitative molecular analyses ofglioma stem cells
    • 批准号:
      23659693
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      ARAKI Norie
    • 依托单位:
    Analysis of cellular signal transduction via Neurofibromatosis tumor suppressor gene products and development of their clinical targets
    • 批准号:
      19390382
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2007
    • 负责人:
      ARAKI Norie
    • 依托单位:
    Study for the cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products to establish the medical molecular target for NF1 and NF2
    • 批准号:
      16390413
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.77万
    • 财政年份:
      2004
    • 负责人:
      ARAKI Norie
    • 依托单位:
    国内基金
    海外基金
    NF1突变驱动破骨细胞激活和增殖的机制研究及其对先天性胫骨假关节的治疗意义
    • 批准号:
      2026JJ82341
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      周天生
    • 依托单位:
    剪接因子 SF3B1 R625 位突变通过高强度异常剪接 NF1/RASA1/RASA2 偏好性 驱动黑色素瘤发生的机制
    NF1 通过调节巨噬细胞极化介导局部微环境在先天 性胫骨假关节发病过程中的作用机制研究
    • 批准号:
      2024JJ5217
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      朱光辉
    • 依托单位: